Serum amyloid A1 isoforms display different efficacy at Toll-like receptor 2 and formyl peptide receptor 2

Immunobiology

Volumn 219, Issue 12, 2014, Pages 916-923

  Chen, Mingjie ^a   Zhou, Huibing ^a   Cheng, Ni ^b   Qian, Feng ^a   Ye, Richard D ^a,b  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b UNIVERSITY OF ILLINOIS   (United States)

Author keywords

Formyl peptide receptors; Inflammation; Innate immunity; Polymorphism; Serum amyloid A; Toll like receptors

Indexed keywords

AMYLOID PROTEIN; CALCIUM; FORMYL PEPTIDE RECEPTOR 2; FORMYLPEPTIDE RECEPTOR; G PROTEIN COUPLED RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 1RN; ISOPROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; SERUM AMYLOID A1.1; SERUM AMYLOID A1.3; SERUM AMYLOID A1.5; SERUM AMYLOID A2.2; TOLL LIKE RECEPTOR 2; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; CYTOKINE; FPR2 PROTEIN, HUMAN; LIPOXIN RECEPTOR; RECOMBINANT PROTEIN; SAA1 PROTEIN, HUMAN; SERUM AMYLOID A;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BONE MARROW DERIVED MACROPHAGE; CALCIUM MOBILIZATION; CHEMOTAXIS; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ASSAY; ENZYME PHOSPHORYLATION; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; AMINO ACID SEQUENCE; ANIMAL; CELL LINE; CHEMISTRY; DRUG EFFECTS; GENE EXPRESSION; GENETICS; HUMAN; IMMUNOLOGY; MACROPHAGE; METABOLISM; MOLECULAR GENETICS; RAT; SEQUENCE ALIGNMENT; SIGNAL TRANSDUCTION;

AMINO ACID SEQUENCE; ANIMALS; CALCIUM; CELL LINE; CHEMOTAXIS; CYTOKINES; GENE EXPRESSION; HUMANS; MACROPHAGES; MICE; MOLECULAR SEQUENCE DATA; PROTEIN ISOFORMS; RATS; RECEPTORS, FORMYL PEPTIDE; RECEPTORS, LIPOXIN; RECOMBINANT PROTEINS; SEQUENCE ALIGNMENT; SERUM AMYLOID A PROTEIN; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 2;

EID: 84990015575     PISSN: 01712985     EISSN: 18783279     Source Type: Journal    
DOI: 10.1016/j.imbio.2014.08.002     Document Type: Article

References (37)

1. Ather J.L., Ckless K., Martin R., Foley K.L., Suratt B.T., Boyson J.E., Fitzgerald K.A., Flavell R.A., Eisenbarth S.C., Poynter M.E. Serum amyloid A activates the NLRP3 inflammasome and promotes Th17 allergic asthma in mice. J. Immunol. 2011, 187:64-73.
2. Baranova I.N., Vishnyakova T.G., Bocharov A.V., Kurlander R., Chen Z., Kimelman M.L., Remaley A.T., Csako G., Thomas F., Eggerman T.L., Patterson A.P. Serum amyloid A binding to CLA-1 (CD36 and LIMPII analogous-1) mediates serum amyloid A protein-induced activation of ERK1/2 and p38 mitogen-activated protein kinases. J. Biol. Chem. 2005, 280:8031-8040.
3. Buxbaum J. The genetics of the amyloidoses: interactions with immunity and inflammation. Genes Immun. 2006, 7:439-449.
4. Cai L., de Beer M.C., de Beer F.C., van der Westhuyzen D.R. Serum amyloid A is a ligand for scavenger receptor class B type I and inhibits high-density lipoprotein binding and selective lipid uptake. J. Biol. Chem. 2005, 280:2954-2961.
5. Cheng N., He R., Tian J., Ye P.P., Ye R.D. Cutting edge: TLR2 is a functional receptor for acute-phase serum amyloid A. J. Immunol. 2008, 181:22-26.
6. El Kebir D., Jozsef L., Khreiss T., Pan W., Petasis N.A., Serhan C.N., Filep J.G. Aspirin-triggered lipoxins override the apoptosis-delaying action of serum amyloid A in human neutrophils: a novel mechanism for resolution of inflammation. J. Immunol. 2007, 179:616-622.
7. Fyfe A.I., Rothenberg L.S., DeBeer F.C., Cantor R.M., Rotter J.I., Lusis A.J. Association between serum amyloid A proteins and coronary artery disease: evidence from two distinct arteriosclerotic processes. Circulation 1997, 96:2914-2919.
8. He H.Q., Troksa E.L., Caltabiano G., Pardo L., Ye R.D. Structural determinants for the interaction of formyl peptide receptor 2 with peptide ligands. J. Biol. Chem. 2014, 289:2295-2306.
9. He R., Sang H., Ye R.D. Serum amyloid A induces IL-8 secretion through a G protein-coupled receptor, FPRL1/LXA4R. Blood 2003, 101:1572-1581.
10. He R., Shepard L.W., Chen J., Pan Z.K., Ye R.D. Serum amyloid A is an endogenous ligand that differentially induces IL-12 and IL-23. J. Immunol. 2006, 177:4072-4079.
11. He R.L., Zhou J., Hanson C.Z., Chen J., Cheng N., Ye R.D. Serum amyloid A induces G-CSF expression and neutrophilia via Toll-like receptor 2. Blood 2009, 113:429-437.
12. Kluve-Beckerman B., Long G.L., Benson M.D. DNA sequence evidence for polymorphic forms of human serum amyloid A (SAA). Biochem. Genet. 1986, 24:795-803.
13. Kushner I., Rzewnicki D. Acute Phase Response 1999, 317-329. Lippincott Willams & Wilkins, Philadelphia. 3rd ed.
14. Lee H.Y., Kim M.K., Park K.S., Bae Y.H., Yun J., Park J.I., Kwak J.Y., Bae Y.S. Serum amyloid A stimulates matrix-metalloproteinase-9 upregulation via formyl peptide receptor like-1-mediated signaling in human monocytic cells. Biochem. Biophys. Res. Commun. 2005, 330:989-998.
15. Lee M.S., Yoo S.A., Cho C.S., Suh P.G., Kim W.U., Ryu S.H. Serum amyloid A binding to formyl peptide receptor-like 1 induces synovial hyperplasia and angiogenesis. J. Immunol. 2006, 177:5585-5594.
16. Lu J., Yu Y., Zhu I., Cheng Y., Sun P.D. Structural mechanism of serum amyloid A-mediated inflammatory amyloidosis. Proc. Natl. Acad. Sci. U. S. A. 2014, 111:5189-5194.
17. Lung H.L., Man O.Y., Yeung M.C., Ko J.M., Cheung A.K., Law E.W., Yu Z., Shuen W.H., Tung E., Chan S.H., Bangarusamy D.K., Cheng Y., Yang X., Kan R., Phoon Y., Chan K.C., Chua D., Kwong D.L., Lee A.W., Ji M.F., Lung M.L. SAA1 polymorphisms are associated with variation in antiangiogenic and tumor-suppressive activities in nasopharyngeal carcinoma. Oncogene 2014, [Epub ahead of print]. 10.1038/onc.2014.12.
18. Malle E., Sodin-Semrl S., Kovacevic A. Serum amyloid A: an acute-phase protein involved in tumour pathogenesis. Cell. Mol. Life Sci. 2009, 66:9-26.
19. Moriguchi M., Kaneko H., Terai C., Koseki Y., Kajiyama H., Inada S., Kitamura Y., Kamatani N. Relative transcriptional activities of SAA1 promoters polymorphic at position -13(T/C): potential association between increased transcription and amyloidosis. Amyloid 2005, 12:26-32.
20. Nanamori M., Cheng X., Mei J., Sang H., Xuan Y., Zhou C., Wang M.W., Ye R.D. A novel nonpeptide ligand for formyl peptide receptor-like 1. Mol. Pharmacol. 2004, 66:1213-1222.
21. O'Hara R., Murphy E.P., Whitehead A.S., FitzGerald O., Bresnihan B. Acute-phase serum amyloid A production by rheumatoid arthritis synovial tissue. Arthritis Res. 2000, 2:142-144.
22. O'Hara R., Murphy E.P., Whitehead A.S., FitzGerald O., Bresnihan B. Local expression of the serum amyloid A and formyl peptide receptor-like 1 genes in synovial tissue is associated with matrix metalloproteinase production in patients with inflammatory arthritis. Arthritis Rheum. 2004, 50:1788-1799.
23. O'Reilly S., Cant R., Ciechomska M., Finnegan J., Oakley F., Hambleton S., van Laar J.M. Serum amyloid A (SAA) induces IL-6 in dermal fibroblasts via TLR2, IRAK4 and NF-kappaB. Immunology 2014, [Epub ahead of print]. 10.1111/imm.12260.
24. Patel H., Fellowes R., Coade S., Woo P. Human serum amyloid A has cytokine-like properties. Scand. J. Immunol. 1998, 48:410-418.
25. Poltorak A., He X., Smirnova I., Liu M.Y., Van Huffel C., Du X., Birdwell D., Alejos E., Silva M., Galanos C., Freudenberg M., Ricciardi-Castagnoli P., Layton B., Beutler B. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 1998, 282:2085-2088.
26. Sandri S., Rodriguez D., Gomes E., Monteiro H.P., Russo M., Campa A. Is serum amyloid A an endogenous TLR4 agonist. J. Leukoc. Biol. 2008, 83:1174-1180.
27. Sodin-Semrl S., Spagnolo A., Mikus R., Barbaro B., Varga J., Fiore S. Opposing regulation of interleukin-8 and NF-kappaB responses by lipoxin A4 and serum amyloid A via the common lipoxin A receptor. Int. J. Immunopharmacol. 2004, 17:145-156.
28. Srinivasan S., Patke S., Wang Y., Ye Z., Litt J., Srivastava S.K., Lopez M.M., Kurouski D., Lednev I.K., Kane R.S., Colon W. Pathogenic serum amyloid A 1.1 shows a long oligomer-rich fibrillation lag phase contrary to the highly amyloidogenic non-pathogenic SAA2.2. J. Biol. Chem. 2013, 288:2744-2755.
29. Su S.B., Gong W., Gao J.L., Shen W., Murphy P.M., Oppenheim J.J., Wang J.M. A seven-transmembrane, G protein-coupled receptor, FPRL1, mediates the chemotactic activity of serum amyloid A for human phagocytic cells. J. Exp. Med. 1999, 189:395-402.
30. Sun L., Zhu Z., Cheng N., Yan Q., Ye R.D. Serum amyloid A induces interleukin-33 expression through an IRF7-dependent pathway. Eur. J. Immunol. 2014, 44:2153-2164.
31. Takase H., Tanaka M., Miyagawa S., Yamada T., Mukai T. Effect of amino acid variations in the central region of human serum amyloid A on the amyloidogenic properties. Biochem. Biophys. Res. Commun. 2014, 444:92-97.
32. Uhlar C.M., Whitehead A.S. Serum amyloid A, the major vertebrate acute-phase reactant. Eur. J. Biochem. 1999, 265:501-523.
33. van der Hilst J.C., Yamada T., Op den Camp H.J., van der Meer J.W., Drenth J.P., Simon A. Increased susceptibility of serum amyloid A 1.1 to degradation by MMP-1: potential explanation for higher risk of type AA amyloidosis. Rheumatology (Oxford) 2008, 47:1651-1654.
34. Xu X.L., Sun X.T., Pang L., Huang G., Huang J., Shi M., Wang Y.Q. Rs12218 In SAA1 gene was associated with serum lipid levels. Lipids Health Dis. 2013, 12:116.
35. Yamada T., Okuda Y., Takasugi K., Wang L., Marks D., Benson M.D., Kluve-Beckerman B. An allele of serum amyloid A1 associated with amyloidosis in both Japanese and Caucasians. Amyloid 2003, 10:7-11.
36. Yan S.D., Zhu H., Zhu A., Golabek A., Du H., Roher A., Yu J., Soto C., Schmidt A.M., Stern D., Kindy M. Receptor-dependent cell stress and amyloid accumulation in systemic amyloidosis. Nat. Med. 2000, 6:643-651.
37. Ye R.D., Boulay F., Wang J.M., Dahlgren C., Gerard C., Parmentier M., Serhan C.N., Murphy P.M. International Union of Basic and Clinical Pharmacology. LXXIII. Nomenclature for the formyl peptide receptor (FPR) family. Pharmacol. Rev. 2009, 61:119-161.